Enocitabine
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | IV |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
55726-47-1 ![]() |
PubChem (CID) | 71734 |
ChemSpider |
64778 ![]() |
UNII |
9YVR68W306 ![]() |
KEGG |
D01633 ![]() |
ChEMBL |
CHEMBL2106589 ![]() |
Chemical and physical data | |
Formula | C31H55N3O6 |
Molar mass | 565.78 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Enocitabine (INN, marketed under the brand name Sunrabin) is a nucleoside analog used as chemotherapy.
Sunrabin contains the emulsifier HCO-60, which can cause allergic reactions.[1]
References
- (Japanese) Sunrabin
This article is issued from Wikipedia - version of the 9/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.